Showing results (41-50 of 194) with videos related to
Sort By:
Pageof 20
European Journal of Gastroenterology & Hepatology|March 13, 2009
Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 casesJean-François Dufour, Pierre Pradat, Marc Ruivard, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2007
Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversionPatrick Miailhes, Mary-Anne Trabaud, Pierre Pradat, et al.The Journal of General Virology|April 19, 2008
DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infectionAlexandre Thermet, Thierry Buronfosse, Bettina Werle-Lapostolle, et al.Gastroenterology|May 2, 2002
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis CThierry Poynard, John McHutchison, Michael Manns, et al.The Journal of Infectious Diseases|April 30, 2004
Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infectionNadege Goutagny, Claude Vieux, Evelyne Decullier, et al.Journal of Medical Virology|January 30, 2019
Non-F HBV/HDV-3 coinfection is associated with severe liver disease in Western Brazilian AmazonEdinete Melo Da Silva, Alan Kay, Cirley Lobato, et al.Cancer Causes & Control : CCC|July 9, 2003
Smoking and non-Hodgkin's lymphoma: a case-control study in the Rhône-Alpes region of FranceHervé Besson, Philippe Renaudier, Ray M Merrill, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 13, 2006
Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis CRaymundo Paraná, Maria Isabel Schinoni, Luiz A R de Freitas, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2006
Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testingDavid Durantel, Marie-Noelle Brunelle, Edwige Gros, et al.Journal of Hepatology|July 10, 2013
Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugsFloriane Pez, Anaïs Lopez, Miran Kim, et al.Pageof 20